GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
N

Novavax NVAX · USD

Health Care · US listing · 🇺🇸 United States

Compare

10.89

+1.02%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Revenue

$1.12bn

FY2016FY2025

Net income

$440.3m

FY2016FY2025

Free cash flow

−$250.2m

FY2016FY2025

Shareholders' equity

−$127.8m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue$1.12bn$682.2m$556.4m$1.60bn$1.15bn$475.6m$18.7m$34.3m$31.2m$15.4m
Research and development$336.8m$391.2m$737.5m$1.24bn$2.53bn$747.0m$113.8m$173.8m$168.4m$237.9m
Operating income$563.3m−$248.9m−$566.5m−$633.8m−$1.69bn−$416.7m−$119.1m−$173.9m−$171.7m−$269.1m
Net income$440.3m−$187.5m−$545.1m−$657.9m−$1.74bn−$427.5m−$130.1m−$184.7m−$183.8m−$280.0m
Diluted earnings per share2.54-1.17-4.41-8.24-23.44-6.50-4.64-9.64-11.63-20.65

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets$1.18bn$1.56bn$1.80bn$2.26bn$2.58bn$1.58bn$173.0m$208.0m$302.5m$394.3m
Cash and short-term investments$735.1m$923.1m$568.5m$1.34bn$1.52bn$711.0m$78.8m$70.2m$106.3m$144.4m
Total liabilities$1.30bn$2.18bn$2.51bn$2.89bn$2.93bn$955.3m$359.0m$375.9m$404.2m$399.8m
Debt$246.7m$230.0m$229.1m$549.8m$454.0m$468.0m$320.6m$319.2m$317.8m$316.3m
Shareholders' equity−$127.8m−$623.8m−$716.9m−$634.1m−$351.7m$627.2m−$186.0m−$167.9m−$101.7m−$5.5m
Shares outstanding173m160m124m80m74m66m28m19m16m14m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−$244.6m−$87.3m−$714.0m−$415.9m$322.9m−$42.5m−$136.6m−$184.8m−$138.7m−$255.5m
Capital spending−$5.6m−$13.1m−$58.8m−$93.0m−$57.5m−$54.6m−$1.9m−$1.4m−$4.2m−$18.2m
Free cash flow−$250.2m−$100.3m−$772.8m−$508.9m$265.5m−$97.2m−$138.5m−$186.2m−$142.9m−$273.7m
Dividends paid—————−$39.1m————

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue$56.7m$139.5m$147.1m$70.4m$239.2m$666.7m$88.3m$84.5m
Operating income−$54.9m−$3.6m$21.0m−$197.6m$111.2m$521.2m−$66.0m−$134.0m
Net income−$53.4m−$9.5m$17.5m−$202.4m$106.5m$518.6m−$81.0m−$121.3m
Diluted earnings per share-0.32-0.060.10-1.170.623.00-0.51-0.76
Cash from operations−$75.0m−$32.0m−$39.0m$107.0m−$127.0m−$185.0m−$173.0m−$144.0m
Capital spending−$1.0m−$1.0m−$2.0m−$2.0m—−$1.0m−$2.0m−$2.0m
Free cash flow−$76.0m−$33.0m−$41.0m$105.0m—−$186.0m−$175.0m−$146.0m
Total assets$955.6m$1.04bn$1.18bn$1.18bn$1.34bn$1.29bn$1.56bn$1.71bn
Cash and short-term investments$719.3m$790.3m$735.1m$762.9m$612.3m$731.5m$923.1m$909.5m
Debt$295.6m$293.2m$246.7m$248.9m$176.1m$175.6m$176.7m$178.9m
Shareholders' equity−$190.7m−$144.8m−$127.8m−$156.7m$37.6m−$75.6m−$623.8m−$526.4m

Financial ratios

Data as of 3 Nov 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Operating margin41.4%-22.9%-95.0%-39.6%-147.1%-87.6%
Net margin39.2%-27.5%-98.0%-41.1%-152.1%-89.9%
Return on equity-344.7%30.1%76.0%103.8%495.8%-68.2%
Return on assets37.4%-12.0%-30.3%-29.1%-67.7%-27.0%
Free cash flow yield-14.5%-4.9%-55.6%-42.5%53.7%1.9%
Revenue growth64.7%22.6%-65.2%39.5%141.0%2448.5%
Earnings growth-334.8%-65.6%-17.2%-62.3%307.9%228.6%
Current ratio2.13x0.98x0.70x0.69x0.90x3.88x
Debt to equity-1.93x-0.28x-0.24x-0.82x-1.29x1.03x
Equity ratio-10.9%-40.0%-39.9%-28.1%-13.6%39.6%
Interest coverage20.61x-7.80x-36.67x-31.88x-79.83x-27.52x
R&D as a share of sales30.0%57.3%132.6%77.3%221.1%157.1%
Buybacks as a share of market value-8.0%-29.6%-54.9%-7.3%-13.2%-134.2%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-11.1%18.8%41.0%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin17.4%-22.4%-53.7%-68.0%
Net margin14.0%-24.0%-55.9%-70.9%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings2.6-6.9-1.1-1.3-6.1-17.1-0.9-1.3-0.7-0.4
Price to sales1.01.91.10.59.315.46.06.84.27.4

Market value over time

30 Dec 2016 to 2 Nov 2026, in USD

$352.8m$1.57bn

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return-23%65%-49%-95%63%2994%-71%83%-21%17%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 20-to-1 reverse split · 10 May 2019

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.